Novastan argatroban: Began Phase II/III trial of safety and efficacy; results should be available by late 1996

By WIR Staff | May 8, 1995 | 7:00 AM GMT

Texas Biotechnology Corp. (TXB), Houston

Read the full 50 word article

How to gain access

Continue reading with a
two-week free trial.